US Stock MarketDetailed Quotes

GLYC GlycoMimetics

Watchlist
  • 0.2666
  • -0.0314-10.54%
Close May 10 16:00 ET
  • 0.2652
  • -0.0014-0.53%
Post 19:00 ET
17.19MMarket Cap-459P/E (TTM)

About GlycoMimetics Company

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.

Company Profile

SymbolGLYC
Company NameGlycoMimetics
Listing DateJan 10, 2014
Issue Price8.00
Founded2003
CEOMr. Harout Semerjian
MarketNASDAQ
Employees35
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9708 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-243-1201
Websitehttp://www.glycomimetics.com

Company Executives

  • Name
  • Position
  • Salary
  • Harout Semerjian
  • Director, President and Chief Executive Officer
  • 2.39M
  • Brian M. Hahn
  • Principal Accounting Officer, Chief Financial Officer and Senior Vice President
  • 1.30M
  • Bruce S. Johnson
  • Chief Commercial Officer and Senior Vice President
  • --
  • Dr. Edwin Rock, M.D.
  • Chief Medical Officer and Senior Vice President
  • 1.15M
  • Chinmaya Rath
  • Chief Business Officer and Senior Vice President
  • --
  • Timothy R. Pearson
  • Chairman of the Board
  • 138.00K
  • Rachel K. King
  • Director
  • 96.00K
  • Scott T. Jackson, M.B.A.
  • Independent Director
  • 111.00K
  • Daniel M. Junius
  • Independent Director
  • 118.50K
  • Dr. Mark Alan Goldberg, M.D.
  • Independent Director
  • 111.00K
  • Patricia S. Andrews
  • Independent Director
  • 105.00K
  • Dr. Scott Koenig, M.D.,PhD
  • Independent Director
  • 100.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg